SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031362
Filing Date
2019-08-12
Accepted
2019-08-12 09:01:38
Documents
72
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grts-10q_20190630.htm 10-Q 2831739
2 EX-31.1 grts-ex311_6.htm EX-31.1 18795
3 EX-31.2 grts-ex312_8.htm EX-31.2 18809
4 EX-32.1 grts-ex321_7.htm EX-32.1 13328
  Complete submission text file 0001564590-19-031362.txt   9473980

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT grts-20190630.xml EX-101.INS 2119646
6 XBRL TAXONOMY EXTENSION SCHEMA grts-20190630.xsd EX-101.SCH 67282
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grts-20190630_cal.xml EX-101.CAL 55015
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grts-20190630_def.xml EX-101.DEF 178695
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20190630_lab.xml EX-101.LAB 474495
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20190630_pre.xml EX-101.PRE 364796
Mailing Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38663 | Film No.: 191014533
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences